Stage IIb/c melanoma research hub

Neoadjuvant pembrolizumab in patients with stage IIb/c melanoma, a phase II double-blind placebo-controlled randomized trial NEOPRIME

This study looks at a new way to treat an advanced type of skin cancer called melanoma before surgery. It tests a drug called pembrolizumab (Keytruda) to see if it can shrink the cancer and make surgery more effective, hoping to improve long-term outcomes for patients.